Response to authors re commentary: Renewed controversy over cardiovascular risk with non-steroidal anti-inflammatory drugs

David Henry; Paulina Stehlik; Laura Rosella

doi:10.1093/ije/dyy051

Response to authors re commentary: Renewed controversy over cardiovascular risk with non-steroidal anti-inflammatory drugs

David Henry^*, Paulina Stehlik, Laura Rosella

^*Corresponding author for this work

Institute for Evidence-Based Healthcare

Research output: Contribution to journal › Comment/debate/opinion › Research › peer-review

2 Citations (Scopus)

Abstract

Brophy and Bally have expressed several concerns about our commentary1 regarding their meta-analysis of observational studies of the use of non-steroidal anti-inflammatory drugs (NSAIDs) and myocardial infarction, published in the BMJ.2 We are grateful for the opportunity to respond to these concerns.

Original language	English
Pages (from-to)	675-676
Number of pages	2
Journal	International Journal of Epidemiology
Volume	47
Issue number	2
DOIs	https://doi.org/10.1093/ije/dyy051
Publication status	Published - 30 Mar 2018

Access to Document

10.1093/ije/dyy051Licence: Free to read

Cite this

@article{0b3c60622d9446c781d3e5447ae8e2ce,

title = "Response to authors re commentary: Renewed controversy over cardiovascular risk with non-steroidal anti-inflammatory drugs",

abstract = "Brophy and Bally have expressed several concerns about our commentary1 regarding their meta-analysis of observational studies of the use of non-steroidal anti-inflammatory drugs (NSAIDs) and myocardial infarction, published in the BMJ.2 We are grateful for the opportunity to respond to these concerns.",

author = "David Henry and Paulina Stehlik and Laura Rosella",

year = "2018",

month = mar,

day = "30",

doi = "10.1093/ije/dyy051",

language = "English",

volume = "47",

pages = "675--676",

journal = "International Journal of Epidemiology",

issn = "0300-5771",

publisher = "OXFORD UNIV PRESS",

number = "2",

}

TY - JOUR

T1 - Response to authors re commentary: Renewed controversy over cardiovascular risk with non-steroidal anti-inflammatory drugs

AU - Henry, David

AU - Stehlik, Paulina

AU - Rosella, Laura

PY - 2018/3/30

Y1 - 2018/3/30

N2 - Brophy and Bally have expressed several concerns about our commentary1 regarding their meta-analysis of observational studies of the use of non-steroidal anti-inflammatory drugs (NSAIDs) and myocardial infarction, published in the BMJ.2 We are grateful for the opportunity to respond to these concerns.

AB - Brophy and Bally have expressed several concerns about our commentary1 regarding their meta-analysis of observational studies of the use of non-steroidal anti-inflammatory drugs (NSAIDs) and myocardial infarction, published in the BMJ.2 We are grateful for the opportunity to respond to these concerns.

UR - http://www.scopus.com/inward/record.url?scp=85055076477&partnerID=8YFLogxK

U2 - 10.1093/ije/dyy051

DO - 10.1093/ije/dyy051

M3 - Comment/debate/opinion

C2 - 29618002

SN - 0300-5771

VL - 47

SP - 675

EP - 676

JO - International Journal of Epidemiology

JF - International Journal of Epidemiology

IS - 2

ER -

Response to authors re commentary: Renewed controversy over cardiovascular risk with non-steroidal anti-inflammatory drugs

Abstract

Access to Document

Other files and links

Fingerprint

Commentary: Renewed controversy over cardiovascular risk with non-steroidal anti-inflammatory drugs

Cite this

Response to authors re commentary: Renewed controversy over cardiovascular risk with non-steroidal anti-inflammatory drugs

Abstract

Access to Document

Other files and links

Fingerprint

Related Research Outputs

Commentary: Renewed controversy over cardiovascular risk with non-steroidal anti-inflammatory drugs

Cite this